Company news
Zentalis Pharmaceuticals, Inc. news in 2020
Zentalis Pharmaceuticals, Inc.'s news releases, calls and decks from 2020, newest first.
Zentalis Pharmaceuticals Reports Third Quarter 2020 Financial Results and Operational Update
November 8, 2020
Zentalis Pharmaceuticals Appoints Alexis Pinto as Chief Legal Officer
August 31, 2020
Zentalis Pharmaceuticals Reports Second Quarter 2020 Financial Results and Operational Update
August 12, 2020
Zentalis Pharmaceuticals Announces Pricing of Upsized Offering of Common Stock
July 28, 2020
Zentalis Pharmaceuticals Enters into Clinical Collaboration with Eli Lilly and Company to Evaluate its Oral SERD ZN-c5 in Combination with Abemaciclib, a CDK4 and 6 Inhibitor
July 26, 2020
Zentalis Pharmaceuticals Announces the Appointment of Dr. Kimberly Blackwell to its Board of Directors
June 30, 2020
Zentalis Pharmaceuticals and Tavros Therapeutics Announce Strategic Platform Collaboration to Discover Next Generation Targeted Small Molecule Therapies
May 27, 2020
Zentalis Pharmaceuticals Announces $20 Million Series A Financing to Establish a Chinese Joint Venture, Zentera Therapeutics
May 19, 2020
Zentalis Pharmaceuticals Reports First Quarter 2020 Financial Results and Operational Update
May 14, 2020
Zentalis Pharmaceuticals Announces FDA Clearance of IND Application for ZN-d5 for the Treatment of Hematologic Malignancies
April 29, 2020
Zentalis Pharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
April 6, 2020
Zentalis Pharmaceuticals Announces Pricing of Initial Public Offering
April 1, 2020